Clinical trials
Major Depressive Disorder trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 10 |
| Not yet recruiting | 3 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gulhane Training and Research Hospital | 4 |
| Istanbul University - Cerrahpasa | 4 |
| Janssen Research & Development, LLC | 3 |
| Eli Lilly and Company | 2 |
| Eskisehir Osmangazi University | 2 |
| Sanofi | 2 |
| Elazığ Mental Health and Diseases Hospital | 1 |
| Erzurum Regional Training & Research Hospital | 1 |
| Inonu University | 1 |
| Istanbul Nisantasi University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 31 |
| Depressive Disorder, Treatment-Resistant | 5 |
| Bipolar Disorder | 4 |
| Depressive Disorder | 3 |
| Mental Disorders | 2 |
| Mood Disorders | 2 |
| Anhedonia | 1 |
| Anxiety Disorders | 1 |
| Catatonia | 1 |
| Generalized Anxiety Disorder | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.